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Abstract
Background:  A  pancreatic  pseudocyst  is  the  collection  of  pancreatic  secretions  surrounded  by
ﬁbrous tissue  caused  by  pancreatic  disease  that  affects  the  pancreatic  duct.  Clinical  presen-
tation is  variable.  Management  includes  percutaneous,  endoscopic  or  surgical  drainage  and
resection.
Material  and  methods:  Review  of  a  cohort  of  patients  with  pancreatic  pseudocyst  in  a  third
level hospital.  An  analysis  was  performed  on  the  demographic  data,  aetiology,  clinical  presenta-
tion, radiological  and  laboratory  ﬁndings,  type  of  surgical  procedure,  complications,  recurrence
and mortality.  The  statistical  analysis  was  performed  using  Chi  squared  and  Student’s  t-tests,
with a  p  <  0.05.
Results:  A  total  of  139  patients  were  included,  of  whom  58%  were  men  and  42%  were  women,
with median  age  of  44.5  years.  Chronic  pancreatitis  was  the  most  common  aetiology,  present  in
74 patients  (53%).  The  main  complaint  was  abdominal  pain  in  73%  of  patients.  Median  size  was
18 cm  (range  7--29)  and  the  most  frequent  location  was  body  and  tail  of  the  pancreas.  Inter-
nal surgical  drainage  was  selected  in  111  (80%)  patients,  of  whom  96  were  cystojejunostomy,
20 (14%)  had  external  surgical  drainage,  and  8  (6%)  resection.  Complications  were,  pancre-
atic ﬁstula  (12%),  haemorrhage  (4%),  infection  (4%),  and  other  non-surgical  complications  (4%).
Complication  rate  was  higher  if  the  cause  was  chronic  pancreatitis  or  if  the  management  was
external  surgical  drainage.  Recurrence  rate  was  6%,  and  a  mortality  rate  of  1%.
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Conclusion:  Surgical  management  is  a  viable  option  for  the  management  of  pancreatic  pseudo-
cyst with  a  low  complication  and  recurrence  rate.
© 2016  Published  by  Masson  Doyma  Me´xico  S.A.  on  behalf  of  Academia  Mexicana  de  Cirug´ıa  A.C.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Tratamiento  quirúrgico  del  seudoquiste  de  páncreas
Resumen
Antecedentes:  El  seudoquiste  de  páncreas  es  la  colección  de  secreciones  pancreáticas  rodeada
de una  pared  ﬁbrosa  secundaria  a  enfermedad  aguda  o  crónica.  El  tratamiento  incluye  drenaje
percutáneo,  endoscópico  o  quirúrgico  y  resección.
El objetivo  es  presentar  la  experiencia  quirúrgica  en  pacientes  con  seudoquiste  de  páncreas.
Material  y  métodos:  Cohorte  retrospectiva  de  139  pacientes  con  diagnóstico  de  seudoquiste
pancreático,  durante  13  an˜os  en  un  hospital  de  tercer  nivel.  Se  estudiaron  datos  demográﬁcos,
etiología,  presentación  clínica,  datos  radiológicos  y  de  laboratorio,  indicación,  tipo  de  proced-
imiento quirúrgico  realizado,  complicaciones,  recurrencia  y  mortalidad.  Se  realizó  prueba  de
Chi cuadrada  para  las  variables  nominales  y  T  de  Student  para  variables  continuas.
Resultados:  Fueron  81  hombres  (58%)  y  58  mujeres  (42%),  con  una  mediana  de  edad  de  44.5
an˜os. En  74  pacientes  (53%)  la  etiología  fue  pancreatitis  crónica.  El  síntoma  más  frecuente
fue dolor  abdominal  en  el  73%.  La  mediana  de  taman˜o  fue  18  cm  (7-29)  y  la  localización  más
frecuente  fue:  cuerpo  y  cola  en  75  pacientes  (54%).  El  tratamiento  fue:  drenaje  interno  en
111 pacientes  (80%),  (96  cistoyeyunoanastomosis),  en  20  (14%)  drenaje  externo  y  resección  en
8 (6%).  Las  complicaciones  fueron:  fístula  pancreática  (12%),  hemorragia  postoperatoria  (4%),
infección  (4%)  y  complicaciones  no  quirúrgicas  (4%).  La  tasa  de  complicaciones  fue  mayor  cuando
el diagnóstico  era  pancreatitis  crónica  y  se  realizó  drenaje  quirúrgico  externo  (p  <  0.05).  Hubo
recurrencia  en  7  pacientes  (6%).  Dos  pacientes  fallecieron  (1%).
Conclusión:  El  tratamiento  quirúrgico  es  una  opción  en  el  manejo  del  seudoquiste  pancreático,
con baja  tasa  de  complicaciones  y  recurrencia.
© 2016  Publicado  por  Masson  Doyma  Me´xico  S.A.  en  nombre  de  Academia  Mexicana  de  Cirug´ıa
A.C. Este  es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.
).
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Background
The  pancreatic  pseudocyst  is  deﬁned  as  a  localised  collec-
tion  of  ﬂuid  rich  in  amylase  and  other  enzymes  surrounded
by  a  ﬁbrous  wall  or  granulation  tissue,  and  resulting  from
an  episode  of  acute  pancreatitis,  chronic  pancreatitis,  pan-
creatic  trauma  or  extrinsic  obstruction  of  the  pancreatic
duct.1,2 It  has  to  have  persisted  for  a  minimum  of  4  weeks
with  or  without  communication  to  the  pancreatic  duct
system.3
The  current  prevalence  of  pancreatic  pseudocysts  is
10--20%  in  patients  with  chronic  pancreatitis.  Alcohol  con-
sumption  is  the  cause  in  65%  of  cases,  followed  by  vesicular
lithiasis  in  15%.1,3
Diagnosis  is  based  on  clinical,  biochemical  and  radio-
logical  ﬁndings.1 Treatment  strategies  for  patients  with
pancreatic  pseudocyst  have  changed  and  continue  to  evolve.
Management  includes  percutaneous  drainage,  internal  endo-
scopic  drainage,  internal  and  external  drainage,  surgery  and
resection.4--6This  study  reports  the  experience  and  results  obtained  in
patients  diagnosed  with  a  pancreatic  pseudocyst  who  under-
went  surgical  treatment  in  a  third  level  hospital  over  a
period  of  13  years.
R
u
aaterial and methods
 retrospective  cohort  was  formed  from  all  patients  diag-
osed  with  a  pancreatic  pseudocyst  who  underwent  surgery
n  the  period  between  1  January  2000  and  31  December
013  in  the  Gastric  Surgery  Department  of  the  Hospital  de
specialidades  de  Centro  Médico  Nacional  Siglo  XXI,  Mexican
ocial  Security  Institute.
Demographic  data  were  obtained  (age  and  gender,  aeti-
logy  (acute,  chronic,  idiopathic  or  traumatic  pancreatitis),
linical  presentation  (pain,  early  satiety,  jaundice,  abdom-
nal  tumour),  laboratory  data  (haemoglobin,  leukocytes,
erum  amylase  and  lipase),  radiological  ﬁndings  (location,
umber  --  single  or  multiple-  and  size),  indication  and
ype  of  surgical  procedure  undertaken  (internal  drainage,
ystogastroanastomosis,  cystoduodenoanastomosis,  cysto-
ejunoanastomosis  --  external  drainage  or  resection)  and
omplications  (wound  infection,  postoperative  bleeding,
ancreatic  or  intestinal  ﬁstula,  dehiscence  of  the  surgi-
al  wound,  pulmonary  and  infectious  thromboembolisms).
ecurrence  rate  and  mortality  were  evaluated  during  follow-
p.
The  data  were  collected  on  a  database  and  the  statistical
nalysis  was  performed  using  SPSS  software  version  16  (SPSS
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nc.,  Chicago,  Ill,  U.S.A.).  The  Chi  squared  test  was  used
or  comparisons  for  nominal  variables  and  the  Student’s  t-
est  for  continuous  variables.  Postoperative  complications
nd  recurrence  were  identiﬁed  as  dependent  variables.  A
-value  <0.05  was  considered  signiﬁcant.
esults
ne  hundred  and  thirty-nine  patients  were  studied,  81  males
58%)  and  58  women  (42%),  with  a  median  age  of  44.5  (range
8--85).  In  74  (53%)  patients  the  aetiology  was  secondary
o  chronic  pancreatitis,  in  52  (37%)  acute  pancreatitis,  in
1  (8%)  idiopathic,  and  in  2  (1%)  patients  it  was  abdominal
rauma.
The  main  symptoms  were:  abdominal  pain  in  101  cases
73%),  weight  loss  in  53  (38%),  postprandial  fullness  or  early
atiety  in  48  (35%),  nausea  and  vomiting  in  47  (34%),  and
ever  in  26  (19%).  The  predominant  sign  on  physical  exam-
nation  was  abdominal  tumours  in  the  epigastrium  in  37
ases  (27%);  2  cases  (1%)  presented  with  symptoms  of  acute
bdomen  secondary  to  rupture.
The  laboratory  tests  revealed  hyperamylasaemia  in  110
atients  (79%)  and  hyperlipasaemia  in  109  (78%);  anaemia  in
5  cases  (18%)  and  leukocytosis  greater  than  10,500/mm3 in
6  (40%).
Computed  tomography  scans  (CT)  were  performed  on  104
atients  (79%)  and  abdominal  ultrasound  on  84  (60%).  Endo-
copic  ultrasound  and  magnetic  resonance  were  used  less
ften  and  only  as  a  diagnostic  complement.  The  median  size
as  18  cm  (range  7--29  cm)  and  the  most  common  location
as  in  the  body  and  tail  in  75  cases  (54%),  body  in  33  (24%),
ead  and  body  in  22  (16%)  and  head  of  pancreas  in  9  cases
6%).
The  surgical  treatment  chosen  was  internal  drainage  in
11  patients  (80%).  Cystojejunoanastomosis  was  performed
n  96  (69%),  cystogastroanastomosis  in  11  (8%)  and  cystoduo-
enoanastomosis  in  4  (3%).  Twenty  patients  (14%)  underwent
xternal  surgical  drainage  and  8  (6%)  resection.
Forty-one  (29%)  patients  presented  postoperative
omplications.  Sixteen  (12%)  patients  developed  a  pan-
reatic  ﬁstula,  9  (6%)  infection,  6  (4%)  postoperative
aemorrhage,  and  6  (4%)  non-surgical  complications,  of
hich  4  were  pneumonia,  one  cardiac  arrhythmia  and
ne  pulmonary  thromboembolism.  Seven  patients  suffered
ecurrence  (6%).  Two  patients  died  for  a  mortality  of  1%;
ne  patient  due  to  haemorrhage  and  the  other  due  to
eptic  shock.  Table  1  summarises  the  surgical  treatment
i
e
p
Table  1  Surgical  treatment,  preoperative  and  postoperative  cha
Surgical  procedure  Size  in  cm  (range)  Postop
Internal  drainage
Cystojejunoanastomosis  (n  =  96)  16  (7--27)  20  (21
Cystogastroanastomosis  (n  =  11)  20  (10--25)  4  (36
Cystoduodenoanastomosis  (n  =  4)  16  (12--23)  1  (25
External drainage  (n  =  20)  19  (8--29)  11  (55
Resection (n  =  8)  18.5  (7--24)  3  (37
Total (139)  18  (7--29)  39  (28J.L.  Martínez-Ordaz  et  al.
ssociated  with  postoperative  complications,  recurrence
nd  mortality.
In  the  analysis  we  performed,  the  factor  associated
ith  postoperative  complications  was  a  greater  presence
f  complications  when  the  aetiology  was  secondary  to
hronic  pancreatitis  (p  <  0.04)  and  with  the  type  of  surgical
rocedure  performed  --  cystojejunoanastomosis  had  fewer
ostoperative  complications  (21%)  compared  with  exter-
al  drainage  (55%,  principally  pancreatic  ﬁstula)  (p  <  0.05).
here  were  no  differences  in  terms  of  recurrence  and  mor-
ality,  in  relation  to  aetiology,  size,  location,  and  type  of
urgical  procedure  undertaken.
iscussion
everal  complications  can  appear  after  an  episode  of  pan-
reatitis  of  which  the  pancreatic  pseudocyst  is  one  of  the
ost  common.  The  pathophysiology,  in  most  patients,  is  the
esult  of  the  lesion  or  alteration  to  the  normal  anatomy  of
he  pancreatic  duct.1
The  aetiology  of  the  pancreatic  pseudocyst  is  directly
ssociated  with  the  cause  of  the  pancreatitis;  the  con-
umption  of  alcohol  is  the  cause  in  65%  of  cases,  followed
y  vesicular  lithiasis  in  15%.  Due  to  improved  imaging
echniques,  the  current  prevalence  is  10--20%  in  patients
fter  acute  pancreatitis  and  20--40%  in  patients  with
hronic  pancreatitis.1,3 In  our  study  the  incidence  was  53%
ssociated  with  chronic  pancreatitis  and  47%  with  acute  pan-
reatitis.  The  prevalence  of  pseudocysts  is  higher  in  males,
etween  the  fourth  and  ﬁfth  decades  of  life,1,3,4 and  both
f  these  results  are  compatible  with  our  study.
Diagnosis  is  made  based  on  clinical,  biochemical  and
adiological  ﬁndings.1 The  clinical  presentation  is  variable,
rom  asymptomatic  patients  to  symptoms  of  abdominal
mergency  due  to  complications.1,3 The  predominant  symp-
oms  reported  in  the  literature  are  abdominal  pain,  which
resents  in  up  to  90%  of  patients,  early  satiety,  nausea  and
omiting  (50--70%),  weight  loss  (20--50%),  jaundice  (10%)
nd  fever  (10%).1 On  physical  examination,  only  25--50%
resented  a  palpable  abdominal  mass.3 There  can  also  be
epsis  secondary  to  infection,  hypovolemic  shock  due  to
leeding7 and  acute  abdomen  after  spontaneous  rupture  of
he  pseudocyst.7 The  clinical  ﬁndings  in  our  study  are  sim-
lar  to  those  reported  in  the  literature  reviewed  and  are
mportant  in  patient  assessment.
There  are  currently  no  speciﬁc  laboratory  studies  to
stablish  a  diagnosis  of  pancreatic  pseudocyst;  however,  a
ersistently  elevated  concentration  of  amylase  and  lipase
racteristics  in  139  patients  with  pancreatic  pseudocyst.
erative  complications  (%)  Recurrence  (%)  Mortality  (%)
)  5  (5)  1  (1)
)  1  (10)  0  (0)
)  1  (25)  0  (0)
)  0  (0)  0  (0)
.5)  0  (0)  12.5
)  7  (5)  2  (1)
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6. Johnson MD, Walsh RM, Henderson JM, Brown N, Ponsky J,
Dumot J, et al. Surgical versus nonsurgical management of pan-Surgical  treatment  of  pancreatic  pseudocysts  
can  be  observed  in  up  to  50%  of  patients.  Other  ﬁndings
include  mild  leukocytosis  and  alterations  in  liver  function
tests.1,4 There  were  elevated  serum  levels  of  the  above-
mentioned  pancreatic  enzymes  in  most  of  our  patients.
Measurement  of  these  is  an  important  part  of  the  diagnostic
protocol  and  therefore  is  recommended  in  our  study.  The
other  biochemical  ﬁndings  in  our  study  were  non-speciﬁc.
With  regard  to  radiological  studies,  CT  is  the  scan  of
choice  for  patients  with  a  suspected  pseudocyst.  It  provides
important  information  about  the  relationship  of  the  lesion
with  adjacent  structures,  the  characteristics  of  the  biliary
and  pancreatic  system,  the  presence  of  calciﬁcations,  the
size  of  the  pseudocyst,  its  extension  and  location;  all  of
these  are  important  factors  in  planning  treatment.  The  sen-
sitivity  and  speciﬁcity  reported  for  CT  scanning  is  90--100%
and  98--100%,  respectively.1,4 Another  widely-used  study  is
ultrasound  which  has  a  sensitivity  of  75--90%  and  speciﬁcity
of  92--98%.  Magnetic  resonance  and  cholangiopancreatogra-
phy  are  viable  options  for  study  and  treatment1,2,4;  however,
they  were  not  used  very  much  in  our  population.  Due  to
the  sensitivity  and  speciﬁcity  of  CT  scanning  reported  in  the
literature  and  its  availability  in  our  hospital,  tomography
was  our  radiological  study  of  choice.  In  some  cases  other
radiological  tools  were  used,  to  complement  the  diagnostic
protocol.
Management  strategies  have  changed  and  continue  to
evolve.2 The  American  College  of  Gastroenterology’s  guide-
lines  for  the  management  of  pancreatitis  of  20138 state  that
an  asymptomatic  pancreatic  pseudocyst  can  be  managed
conservatively  irrespective  of  its  size,  location  or  exten-
sion  to  neighbouring  structures.  This  is  contrary  to  what
was  reported  previously,  when  it  was  recommended  that
the  lesion  should  be  drained  if  it  was  greater  than  6  cm  in
size  or  had  persisted  longer  than  6  weeks.9 These  guidelines
recommend  invasive  management  to  treat  pancreatic  pseu-
docysts  only  if  there  are  symptoms  due  to  the  lesion  itself
or  because  it  has  extended  to  neighbouring  structures  and  is
compromising  normal  gastrointestinal  physiology  (infected
pseudocyst,  bleeding,  biliary  obstruction  or  delayed  gastric
emptying).9--12
At  present  management  includes  percutaneous,  endo-
scopic  or  surgical  drainage,  each  of  which  has  its  different
advantages  and  disadvantages.13 We  did  not  ﬁnd  any  con-
trolled  prospective  studies  that  directly  compare  one  with
another.  It  is  not  easy  to  establish  which  therapeutic
drainage  method  is  better  than  the  rest,  however,  the
management  chosen  will  depend  on  the  patient’s  clinical
characteristics  and,  ideally,  on  the  anatomy  of  the  pan-
creatic  duct.  According  to  Park  and  Heniford,14 Nealon
and  Walser  described  a  classiﬁcation  where  they  took
into  account  the  presence  of  stenosis  or  obstruction  of
the  pancreatic  duct  and  the  communication  of  the  pseu-
docyst  to  it.  Therefore,  appropriate  patient  selection,
the  underlying  cause  of  the  pancreatitis,  the  location  of
the  pseudocyst,  and  the  presence  or  absence  of  obstruc-
tion  of  the  pancreatic  duct  are  important  factors  which
will  determine  the  outcome  of  the  drainage  method
chosen.The  treatment  of  choice  in  our  study  was  surgery;
this  is  still  considered  the  gold  standard,  and  is  divided
between  internal,  external  drainage  and  resection.  Inter-
nal  drainage  can  be  performed  by  communication  between291
he  pseudocyst  and  the  stomach  (cystogastroanasto-
osis),  jejunum  (cystojejunoanastomosis)  or  duodenum
cystoduodenoanastomosis).8,14,15 The  choice  of  any  of  these
echniques  will  depend  on  the  location  of  the  pseudocyst,
he  adjacent  structures  and  the  surgeon’s  preference.  If
esection  is  chosen,  this  will  depend  on  the  location  of  the
seudocyst,  and  a  distal  pancreatectomy  or  even  pancreati-
oduodenectomy  can  be  performed.8
The  surgical  drainage  chosen  in  our  study  was  cystoje-
unoanastomosis  in  almost  7  out  of  10  of  our  patients.  A
ower  rate  of  complications  is  reported  in  the  literature
hen  this  approach  is  chosen  compared  to  other  types  of
nternal  drainage.16 Nevertheless,  our  study  did  not  demon-
trate  a  difference  in  terms  of  the  rate  of  complications
ompared  with  other  internal  drainage  approaches.  How-
ver,  we  did  ﬁnd  these  differences  when  compared  with
xternal  drainage,  where  we  found  a  high  prevalence  of
ancreatic  ﬁstula;  therefore  this  is  not  a  procedure  that  we
erform  frequently  in  our  hospital.
Surgical  drainage  has  a  mortality  of  5--9%,  with  a  mean
f  complications  of  around  11--24%  and  5--8%  recurrence.2,15
he  recurrence  reported  in  our  study  was  6%  with  1%  mor-
ality,  this  coincides  with  that  reported  in  the  literature.
onclusion
he  rate  of  complications  and  recurrence  in  our  study
oincides  with  that  reported  in  the  literature.  Open  or
aparoscopic  surgical  management  with  internal  drainage
mainly  towards  the  jejunum)  is  a viable  and  very  important
ption  in  patients  with  a diagnosis  of  pancreatic  pseudocyst,
as  a  high  resolution  rate  and  low  prevalence  of  postopera-
ive  complications.
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